Online citations, reference lists, and bibliographies.
← Back to Search

Magnetic Nanoparticles As A Drug Delivery System That Enhance Fungicidal Activity Of Polyene Antibiotics.

K. Niemirowicz, B. Durnaś, G. Tokajuk, Katarzyna Głuszek, A. Z. Wilczewska, Iwona Misztalewska, J. Mystkowska, Grzegorz Michalak, Anna Sodo, Marzena Wątek, B. Kiziewicz, S. Góźdź, S. Głuszek, R. Bucki
Published 2016 · Medicine, Materials Science
Referenced 2 times by Citationsy Users

Cite This
Download PDF
Analyze on Scholarcy
Share
This study was designed to assess the antifungal/anti-biofilm and hemolytic properties of two polyene antibiotics, amphotericin B (AMF) and nystatin (NYS), attached to the surface of magnetic nanoparticles (MNP) against clinical isolates of Candida species and human red blood cells, respectively. The developed nanosystems, MNP@AMF and MNP@NYS, displayed stronger fungicidal activity than unbound AMF or NYS. Synergistic activity was observed with a combination of polyenes and MNPs against all tested Candida strains. Nanosystems were more potent than unbound agents when tested against Candida strains in the presence of pus, and as agents able to prevent Candida biofilm formation. The observed inactivation of catalase Cat1 in Candida cells upon treatment with the nanosystems suggests that disruption of the oxidation-reduction balance is a mechanism leading to inhibition of Candida growth. The significant decrease of polyenes lytic activity against host cells after their attachment to MNPs surface indicates improvement in their biocompatibility.
This paper references
10.1097/MCC.0b013e32833e10e8
Prophylaxis, empirical and preemptive treatment of invasive candidiasis
E. Playford (2010)
10.2147/IJN.S47351
Flower-shaped ZnO nanoparticles synthesized by a novel approach at near-room temperatures with antibacterial and antifungal properties
M. F. Khan (2014)
10.1128/AAC.01351-12
Antifungal Lock Therapy
Carla J. Walraven (2012)
10.1016/S0966-842X(01)02094-7
Virulence factors of Candida albicans.
R. Calderone (2001)
10.1371/journal.pone.0108876
Ultrastructural Analysis of Candida albicans When Exposed to Silver Nanoparticles
R. Vazquez-Muñoz (2014)
10.1128/mBio.01333-14
Novel Entries in a Fungal Biofilm Matrix Encyclopedia
R. Żarnowski (2014)
10.1007/s10856-010-4214-2
Magnetically mediated release of ciprofloxacin from polyvinyl alcohol based superparamagnetic nanocomposites
A. K. Bajpai (2011)
10.1021/ES800408U
Bactericidal effect of zero-valent iron nanoparticles on Escherichia coli.
C. Lee (2008)
10.1016/j.jpor.2014.07.004
Susceptibility of Candida albicans and Candida glabrata biofilms to silver nanoparticles in intermediate and mature development phases.
Douglas Roberto Monteiro (2015)
10.1159/000094668
Principles of Antibiotic Penetration into Abscess Fluid
C. Wagner (2006)
10.1186/1471-2334-6-126
Limitations of caspofungin in the treatment of obstructive pyonephrosis due to Candida glabrata infection
S. Schelenz (2006)
10.1371/journal.pone.0085836
In Vitro and In Vivo Activity of a Novel Antifungal Small Molecule against Candida Infections
S. S. W. Wong (2014)
10.1177/0885066609355262
Invasive Fungal Infections in the ICU
S. Shoham (2010)
10.1186/1471-2180-14-182
Biofilms formed by Candida albicans bloodstream isolates display phenotypic and transcriptional heterogeneity that are associated with resistance and pathogenicity
L. Sherry (2014)
10.1093/cid/cit588
Nephrotoxicity of different formulations of amphotericin B: summarizing evidence by network meta-analysis.
A. Messori (2013)
10.1016/j.micinf.2009.04.018
Biofilm formation in clinical Candida isolates and its association with virulence.
Fahmi Hasan (2009)
10.1111/J.1574-6968.1990.TB04231.X
Antifungal drugs affect adherence of Candida albicans to acrylic surfaces by changing the zeta-potential of fungal cells.
Y. Miyake (1990)
10.1016/J.MIB.2007.04.001
Infection-related gene expression in Candida albicans.
A. Brown (2007)
10.1021/cr300068p
Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications.
L. H. Reddy (2012)
10.1590/0037-8682-0190-2013
Fluconazole and amphotericin-B resistance are associated with increased catalase and superoxide dismutase activity in Candida albicans and Candida dubliniensis.
C. B. Linares (2013)
10.1086/589290
Immunocompromised hosts: immunopharmacology of modern antifungals.
R. Ben-Ami (2008)
10.1016/S0966-842X(03)00117-3
Antifungal agents: mechanisms of action.
F. Odds (2003)
10.1016/j.jconrel.2011.07.002
"Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.
Ae Jung Huh (2011)
Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard
J. Rex (2008)
10.2147/IJN.S53079
Synthesis, characterization, controlled release, and antibacterial studies of a novel streptomycin chitosan magnetic nanoantibiotic
S. Hussein-Al-Ali (2014)
10.1007/s40265-013-0069-4
Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity
R. Hamill (2013)
10.1155/2014/651831
Antimicrobial and Controlled Release Studies of a Novel Nystatin Conjugated Iron Oxide Nanocomposite
S. Hussein-Al-Ali (2014)
10.1128/AAC.01106-08
Synergistic Interaction between Silver Nanoparticles and Membrane-Permeabilizing Antimicrobial Peptides
Serge Ruden (2009)
10.1128/JCM.39.12.4256-4263.2001
Comparison of Spectrophotometric and Visual Readings of NCCLS Method and Evaluation of a Colorimetric Method Based on Reduction of a Soluble Tetrazolium Salt, 2,3-Bis {2-Methoxy-4-Nitro-5-[(Sulfenylamino) Carbonyl]-2H- Tetrazolium-Hydroxide}, for Antifungal Susceptibility Testing of AspergillusSpeci
J. Meletiadis (2001)
10.3390/ijms16012099
Antimicrobial Polymers with Metal Nanoparticles
H. Palza (2015)
10.1093/JAC/44.1.27
Rhodamine 6G efflux for the detection of CDR1-overexpressing azole-resistant Candida albicans strains.
S. Maesaki (1999)
10.1016/j.colsurfb.2015.04.016
Growth arrest and rapid capture of select pathogens following magnetic nanoparticle treatment.
K. Niemirowicz (2015)
10.1128/AAC.42.8.1900
Effect of Growth Rate on Resistance ofCandida albicans Biofilms to Antifungal Agents
G. Baillie (1998)
10.2165/00003495-200868140-00002
Patients at High Risk of Invasive Fungal Infections
M. Rüping (2012)
10.6026/97320630010667
Anti-fungal resistance in candida isolated from oral and diaper rash candidiasis in neonates
J. Mohamadi (2014)
10.1128/AAC.00684-06
Candida albicans Biofilms Produce Antifungal-Tolerant Persister Cells
Michael D Lafleur (2006)
10.1016/j.saa.2011.05.043
Combustion synthesis, characterization and Raman studies of ZnO nanopowders.
A. Reddy (2011)
10.2147/IJN.S38256
Short communication: carboxylate functionalized superparamagnetic iron oxide nanoparticles (SPION) for the reduction of S. aureus growth post biofilm formation
Kohana Leuba (2013)
10.1016/S0024-3205(00)00560-9
Amphotericin B-induced apoptosis and cytotoxicity is prevented by the Na+, K+, 2Cl(-)-cotransport blocker bumetanide.
L. Marklund (2000)
10.1128/AAC.01638-09
Interaction of Candida albicans Biofilms with Antifungals: Transcriptional Response and Binding of Antifungals to Beta-Glucans
G. Vediyappan (2010)
10.1371/journal.pone.0106578
Understanding Neighborhood Environment Related to Hong Kong Children’s Physical Activity: A Qualitative Study Using Nominal Group Technique
G. He (2014)
10.2147/IJN.S50113
NanoDisk containing super aggregated amphotericin B: a high therapeutic index antifungal formulation with enhanced potency
Braydon L. Burgess (2013)
10.1074/jbc.M306137200
The Antifungal Drug Amphotericin B Promotes Inflammatory Cytokine Release by a Toll-like Receptor- and CD14-dependent Mechanism*
K. Sau (2003)
10.1109/TMAG.1981.1061188
Preparation of aqueous magnetic liquids in alkaline and acidic media
R. Massart (1981)
[Multipurpose treatment of vaginal infections].
Aleksandar Nikolov (2012)
10.1016/S1734-1140(12)70901-5
Nanoparticles as drug delivery systems.
A. Z. Wilczewska (2012)
10.1016/j.tim.2011.02.003
Adherence and biofilm formation of non-Candida albicans Candida species.
S. Silva (2011)
10.4149/BLL_2012_160
The evaluation of Candida albicans biofilms formation on silicone catheter, PVC and glass coated with titanium dioxide nanoparticles by XTT method and ATPase assay.
F. Haghighi (2012)
[Candida infections of the oral mucosa--not only a dental problem].
H. Kempa (2006)
10.1111/jam.12652
Synthesis, characterization and antifungal activity of chemically and fungal‐produced silver nanoparticles against Trichophyton rubrum
L. Pereira (2014)
10.3390/molecules19011085
Invasive Fungal Infections in the ICU: How to Approach, How to Treat
E. Paramythiotou (2014)
10.1159/000007295
Comparative in vitro Antifungal Activity of Amphotericin B Lipid Complex, Amphotericin B and Fluconazole
A. Carrillo-Muñoz (2000)
10.1016/j.diagmicrobio.2015.06.015
Candida tropicalis biofilm's matrix--involvement on its resistance to amphotericin B.
T. Fernandes (2015)
Antibiotics induced acute kidney injury: incidence, risk factors, onset time and outcome.
H. Khalili (2013)
10.2478/v10039-012-0031-9
Magnetic nanoparticles as new diagnostic tools in medicine.
K. Niemirowicz (2012)
10.1186/s12951-015-0093-5
Bactericidal activity and biocompatibility of ceragenin-coated magnetic nanoparticles
K. Niemirowicz (2015)
10.1111/j.1439-0507.2008.01572.x
Antifungal treatment strategies in high risk patients
M. Rüping (2008)
10.2147/IJN.S56588
Gold-functionalized magnetic nanoparticles restrict growth of Pseudomonas aeruginosa
K. Niemirowicz (2014)
10.1155/2014/786892
Fabrication and Characteristics of Chitosan Sponge as a Tissue Engineering Scaffold
T. Ikeda (2014)
10.1016/0002-9343(89)90014-4
Effect of the abscess environment on the antimicrobial activity of ciprofloxacin.
R. Bryant (1989)
10.1042/BJ0930440
Studies on the intracellular localization and incorporation of 59Fe into catalase in rat liver.
T. M. Radhakrishnan (1964)



This paper is referenced by
10.1039/c7nr04724j
Characterization of carboxylate nanoparticle adhesion with the fungal pathogen Candida albicans.
Amy Lyden (2017)
10.4155/tde-2019-0011
Biocide-conjugated magnetite nanoparticles as an advanced platform for biofilm treatment.
Viktoriya Rumyantceva (2019)
10.3390/antibiotics7020046
Iron Oxide Nanoparticles for Biomedical Applications: A Perspective on Synthesis, Drugs, Antimicrobial Activity, and Toxicity
L. S. Arias (2018)
10.2217/nnm-2017-0052
Development of antifungal therapies using nanomaterials.
K. Niemirowicz (2017)
10.1038/s41598-017-04653-1
Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13
K. Niemirowicz (2017)
10.3389/fmicb.2017.02678
Overcoming Antimicrobial Resistance in Bacteria Using Bioactive Magnetic Nanoparticles and Pulsed Electromagnetic Fields
V. Novickij (2018)
10.1007/978-981-15-0391-7
Nanoparticles and their Biomedical Applications
Ajit Kumar N. Shukla (2020)
10.3389/fcimb.2020.00463
Therapies and Vaccines Based on Nanoparticles for the Treatment of Systemic Fungal Infections
Brenda Kischkel (2020)
10.1016/J.ARABJC.2016.12.014
Carbamohydrazonothioate-based polymer-magnetic nanohybrids: Fabrication, characterization and bactericidal properties
Karolina H. Markiewicz (2016)
10.3389/fmicb.2017.00336
Antifungal Therapy for Systemic Mycosis and the Nanobiotechnology Era: Improving Efficacy, Biodistribution and Toxicity
A. C. Souza (2017)
10.1016/j.micpath.2016.08.031
Amphotericin B-conjugated biogenic silver nanoparticles as an innovative strategy for fungal infections.
A. Ahmad (2016)
10.1007/s11051-018-4346-8
Immobilization of carborane derivatives on Ni/Fe nanotubes for BNCT
I. Korolkov (2018)
10.1007/s00253-020-10391-8
Generation of tetramycin B derivative with improved pharmacological property based on pathway engineering
Yong Sheng (2020)
10.1016/j.tiv.2020.104824
In vitro toxicological characterisation of the antifungal compound soybean toxin (SBTX).
MarianaReis Arantes (2020)
10.1186/s12951-019-0566-z
Nanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools: current status and potential future applications
Urszula Wnorowska (2020)
10.1016/j.ijpharm.2018.11.043
Antimicrobial magnetic nanoparticles based-therapies for controlling infectious diseases.
Gisele Regina Rodrigues (2019)
10.1007/978-981-15-0391-7_7
Use of Nanoparticles to Manage Candida Biofilms
Douglas Roberto Monteiro (2020)
10.1007/s11095-016-2062-6
Preparation, Physicochemical Characterization and Anti-fungal Evaluation of Nystatin-Loaded PLGA-Glucosamine Nanoparticles
Ghobad Mohammadi (2016)
10.2147/IJN.S157564
Bactericidal and immunomodulatory properties of magnetic nanoparticles functionalized by 1,4-dihydropyridines
Katarzyna Niemirowicz-Laskowska (2018)
10.1016/B978-0-323-46152-8.00009-3
Antimicrobial Thin Coatings Prepared by Laser Processing
R. Popescu (2017)
10.3389/fmicb.2017.00036
Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis
L. Scorzoni (2017)
Functionalization of Magnetic Nanoparticles for Drug Delivery
(2018)
10.2147/IJN.S193981
A perspective on magnetic core–shell carriers for responsive and targeted drug delivery systems
Kholoud E Albinali (2019)
10.1002/9783527344758.CH3
Biosynthesized Nanobullets for Microbes and Biofilms
Lubna Sherin (2018)
10.1186/s12951-019-0511-1
Susceptibility of microbial cells to the modified PIP2-binding sequence of gelsolin anchored on the surface of magnetic nanoparticles
R. Bucki (2019)
10.2217/nnm-2017-0051
Enhancing the fungicidal activity of antibiotics: are magnetic nanoparticles the key?
Katarzyna Niemirowicz (2017)
10.2147/IJN.S140661
Use of magnetic nanoparticles as a drug delivery system to improve chlorhexidine antimicrobial activity
G. Tokajuk (2017)
10.2147/IDR.S164262
Efficiency of gold nanoparticles coated with the antimicrobial peptide indolicidin against biofilm formation and development of Candida spp. clinical isolates
E. de Alteriis (2018)
10.1007/s11094-019-01922-3
Polyene Macrolide Antibotic Derivatives: Preparation, Overcoming Drug Resistance, and Prospects for Use in Medical Practice (Review)
V. Belakhov (2019)
10.1016/j.colsurfb.2018.05.017
Preparation and characterization of iron oxide magnetic nanoparticles functionalized by nisin.
Ru̅ta Gruškienė (2018)
10.3389/fmicb.2017.00980
A Chitin-binding Protein Purified from Moringa oleifera Seeds Presents Anticandidal Activity by Increasing Cell Membrane Permeability and Reactive Oxygen Species Production
J. X. Neto (2017)
10.34172/apb.2020.063
Magnetic Nanosystems as a Therapeutic Tool to Combat Pathogenic Fungi
Heba S. Abbas (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar